Corneal Implants Market Report 2026

Corneal Implants Market Overview

• Corneal Implants market size has reached to $1.42 billion in 2025 • Expected to grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Elevated Healthcare Expenditure Propels Advancements In Corneal Implants Market • Market Trend: Innovative Corneal Implants And Techniques Enhance Surgical Precision And Patient Outcomes • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Corneal Implants Market?

Corneal implants refer to a surgical procedure that involves the replacement or augmentation of a damaged or diseased cornea with an artificial or prosthetic device. Corneal implants are surgically implanted into the cornea of the eye to improve vision and relieve pain. The main types of corneal implants are artificial corneal implants and human corneal implants. An artificial corneal implant refers to a medical device designed to replace a damaged or diseased cornea. There are various procedures for corneal implants, including endothelial keratoplasty, penetrating keratoplasty, and others for different applications such as keratoconus, fuchs dystrophy, infectious keratitis, corneal ulcers, and others. These are conducted in hospitals, ophthalmic centers, and others.

What Is The Corneal Implants Market Growth Forecast?

The corneal implants market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing investments in regenerative ophthalmology, rising demand for vision restoration procedures, expansion of advanced eye care facilities, growing adoption of bioengineered implants, increasing focus on long-term implant durability. Major trends in the forecast period include increasing adoption of artificial corneal implants, rising use of advanced keratoplasty techniques, growing focus on biocompatible implant materials, expansion of specialized ophthalmic surgical centers, enhanced precision in corneal transplant procedures.

Global Corneal Implants Market Segmentation

1) By Implant Type: Artificial Corneal Implant, Human Corneal Implant 2) By Procedure Type: Endothelial Keratoplasty, Penetrating Keratoplasty, Other Procedure Types 3) By Application: Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, Other Applications 4) By End-User: Hospitals, Ophthalmic Center, Other End-Users Subsegments: 1) By Artificial Corneal Implant: Keratoprosthesis, Artificial Cornea 2) By Human Corneal Implant: Donor Cornea, Preserved Cornea

What Is The Driver Of The Corneal Implants Market?

The increasing healthcare expenditure is expected to boost the growth of the corneal implants market going forward. Healthcare expenditure refers to the total amount of resources, including financial resources, spent on healthcare goods and services within a specific period in a given geographical area. Increased healthcare spending allows for the adoption of advanced technologies and surgical techniques in the field of ophthalmology, including corneal implants. For instance, in May 2024, according to Office of National Statistics a UK-based government agency, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the corneal implant industry.

Key Players In The Global Corneal Implants Market

Major companies operating in the corneal implants market are Alcon Inc., Bausch & Lomb Incorporated, Johnson & Johnson Vision, ZEISS Group, AJL Ophthalmic SA, CorNeat Vision Ltd., EyeYon Medical Ltd., Precise Bio Inc., CorneaGen, Cornea Biosciences LLC, Linkocare Life Sciences AB, MediPhacos, Coroneo Pty Ltd., KeraMed Inc., DIOPTEX Co. Ltd., HumanOptics AG, Morcher GmbH, Moria SA, DORC International BV, Aurolab (Aravind Eye Care System)

Global Corneal Implants Market Trends and Insights

Major companies in the corneal implants market focusing on developing innovative corneal contouring solutions to enhance vision correction and treat various corneal disorders.Innovative corneal contouring solutions refer to advanced surgical techniques and devices designed to reshape the cornea for improved vision and the treatment of refractive errors or corneal diseases. for instance, in June 2024, CorneaGen, a US-based developer of medical devices designed to eliminate corneal blindness, launched Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes.CTAK utilizes a novel technique of adding donor corneal tissue to the existing cornea, rather than replacing it entirely. This method aims to restore the natural contour of the cornea, enhancing optical clarity.

What Are Latest Mergers And Acquisitions In The Corneal Implants Market?

In January 2023, Viatris Inc., a US-based pharmaceutical and healthcare corporation, acquired Oyster Point Pharma and Family Life Sciences for $415 million and $280 million, respectively. With these acquisitions, Viaris Inc. aims to increase its commercial footprint and portfolio, establish itself as a global leader in eye care, and satisfy the unmet requirements of patients with ophthalmic disease and eye care professionals. Oyster Point Pharma is a US-based biopharmaceutical company specializing in identifying, creating, and marketing novel treatments for eye diseases. Family Life Sciences is an Indian drug development platform specializing in ophthalmology.

Regional Outlook

North America was the largest region in the cornea implants market in 2025. Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Corneal Implants Market?

The corneal implants market includes revenues earned by entities by providing corneal implantation services, including deep anterior lamellar keratoplasty (DALK) and Descemet rhexis without endothelial keratoplasty (DWEK). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.